CareNatal DHA Tablets
Marketed by: ETHEX Corp (St. Louis, Mo)
Compared to: StuartNatal Duet DHA (Xanodyne Pharmaceuticals Inc)
Indication: January 15, 2007?ETHEX Corp introduced CareNatal DHA, the first and only multisource prescription prenatal vitamin with DHA (docosahexaenoic acid). CareNatal DHA is indicated for use in improving the nutritional status of women prior to conception, throughout pregnancy, and in the postnatal period for both lactating and nonlactating mothers. Health care professionals can compare the active ingredients on the label of CareNatal DHA with the active ingredients on the label of StuartNatal Duet DHA. The product contains a multivitamin (with 15 vitamins and minerals, including 29 mg of iron) and a DHA soft gelatin capsule of 250 mg of purified omega-3 fatty acid.
Dosage Form: 5 unit-dose cards of 6 prenatal multivitamin/multimineral tablets and 6 omega-3 fatty-acid soft gelatin capsules
For More Information: www.ethex.com
Ciclopirox Topical Suspension USP, 0.77%
Marketed by: Perrigo Co (Allegan, Mich)
Compared to: Loprox Topical Suspension, 0.77% (Medicis Pharmaceutical Corp)
Indication: December 19, 2006?The Perrigo Co announced that it received FDA approval to manufacture and market Ciclopirox Topical Suspension USP, 0.77%. This lotion is an antifungal medication indicated for the topical treatment of common skin infections such as tinea pedis (athlete's foot), tinea cruris (jock itch), and tinea corporis (ringworm) due to Trichophyton rubrum, T mentagrophytes, Epidermophyton floccosum, and Microsporum canis.
Dosage Form: 60-mL bottle
For More Information: www.perrigo.com
Ondansetron Hydrochloride Tablets, 4, 8, 16, and 24 mg
Marketed by: Dr. Reddy's Laboratories Ltd (Hyderabad, India)
Compared to: Zofran (GlaxoSmithKline)
Indication: December 27, 2006?Dr. Reddy's Laboratories announced that the FDA granted final approval for its abbreviated new drug application (ANDA) for Ondansetron Hydrochloride Tablets, 4, 8, 16, and 24 mg. Because the company was the first to file an ANDA containing a paragraph IV certification for this product, Dr. Reddy's has been awarded a period of 180 days of marketing exclusivity. These tablets are indicated for the prevention of nausea and vomiting associated with surgery, radiotherapy, and cancer treatment.
Dosage Form: Tablets: 4, 8, 16, and 24 mg
For More Information: www.drreddys.com
Sulfamethoxazole and Trimethoprim Oral Suspension USP
Marketed by: Teva Pharmaceuticals (North Wales, Pa)
Compared to: Septra Suspension (Monarch Pharmaceuticals Inc)
Indication: December 22, 2006?Teva Pharmaceuticals announced the introduction and availability of Sulfamethoxazole and Trimethoprim Oral Suspension USP. To reduce the development of drug-resistant bacteria and maintain the effectiveness of sulfamethoxazole and trimethoprim and other antibacterial drugs, this product should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. It may be used for the treatment of such infections as urinary tract infections, acute otitis media, and acute exacerbations of chronic bronchitis in adults, among others, caused by susceptible bacteria.
Dosage Form: 473-mL bottle: 200 mg/40 mg/5-mL strength
For More Information: www.tevausa.com
One study linked multiple pregnancies to an increased risk of developing atrial fibrillation later in life, and another investigated the association between premature delivery and cardiovascular disease.
Clinical features with downloadable PDFs